Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis

Total article views   Abstract views HTML views PDF downloads Totals
2,634 Dovepress* 2,068 336+ 734 2,404
PubMed Central* 0 230 79 230
Totals 2,068 566 813 2,634
*Since 24 September 2020
+Since July 2016

View citations on PubMed Central and Google Scholar